Glucaric acid as an indicator of use of enzyme-inducing drugs.
D000272:Adipates / Q000652:urine*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001463:Barbiturates / Q000494:pharmacology*; D002446:Celiac Disease / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003348:Cortisone / Q000494:pharmacology*; D003480:Cushing Syndrome / Q000188:drug therapy; D003632:Dichlorodiphenyldichloroethane / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D004790:Enzyme Induction / Q000187:drug effects*; D005215:Fasting; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D016030:Kidney Transplantation; D008099:Liver / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000494:pharmacology*; D011241:Prednisone / Q000494:pharmacology*; D013400:Sugar Acids / Q000652:urine*; D013997:Time Factors; D014184:Transplantation, Homologous
D000272:Adipates; D001463:Barbiturates; D006634:Histamine H1 Antagonists; D013400:Sugar Acids; D010653:Phenylbutazone; D003632:Dichlorodiphenyldichloroethane; D003348:Cortisone; D011241:Prednisone